Latest News
Roslin Technologies, the UK’s specialist AgriTech venture builder, has invested in Singapore-based Protenga, a business which farms black soldier fly insects to produce animal feed and fertiliser. As part of Roslin Technologies’ ambitious programme, a bespoke genetic nucleus facility is being built near its HQ, which will focus on applying enhanced breeding technologies to develop improved insect lines together with Protenga for the global market.
These investments align with Roslin Technologies’ focus on developing alternative protein sources to help overcome the impending global food deficit and are central to Protenga’s mission to provide sustainable food sources to livestock, aquaculture and
CEPRES has appointed Tony Chung as Chief Business Development Officer. In this role, he will be responsible for all aspects of business development for CEPRES’ core products and for further expanding CEPRES’ market penetration as a fast growing and innovative Private Equity Fintech Company.
Investcorp, a global provider and manager of alternative investment products, has appointed Jordana Semaan, Head of HR Gulf and Asia into a newly established role as Diversity & Inclusion (D&I) Champion, reporting directly to the Executive Chairman, Mohammed Alardhi. The firm has also announced a series of initiatives to enhance its D&I global practices.
Mohammed Alardhi, Executive Chairman of Investcorp, says: “At Investcorp, we believe that having a diverse mix of skills, perspectives, backgrounds and expertise are key drivers of our success, which is why they are embedded into our daily operations. We are committed to fostering a diverse and inclusive
KPS Capital Partners (KPS), through a newly formed affiliate, has entered into an asset purchase agreement to acquire substantially all of the assets of Briggs & Stratton, including equity of foreign subsidiaries, for approximately USD550 million.
Briggs & Stratton has filed a motion with the United States Bankruptcy Court for the Eastern District of Missouri seeking the designation of KPS as the stalking horse bidder in a sale motion as part of the Company’s filing of voluntary petitions under Chapter 11 of the Bankruptcy Code today. Briggs & Stratton expects to sell its assets through a court-supervised sale process under
Aquiline Capital Partners, a global private investment firm specialising in financial services and technology, has closed its investment in Quintes Holding, one of the largest independent insurance brokers in the Netherlands.
Since its founding in 2012, Quintes has built a national footprint of brokers with a focus on serving the Dutch SME sector.
The Company will maintain its corporate headquarters in Culemborg under the continued leadership of the existing management including CEO Gijsbert van de Nieuwegiessen and CFO Alex Klooster.
“The Dutch insurance market presents significant opportunities for continued growth, M&A activity and the need for a dedicated,
MUFG Investor Services, a specialist in administration, asset servicing, banking and fund financing, has selected Broadridge’s Sentry loan tracking and reporting technology to service its clients in the private debt space.
With recent growth in the private debt, private credit and direct lending market, and the growing demand for software capable of administering and handling loans, MUFG Investor Services has chosen to partner with Broadridge to implement its Sentry Loan Portfolio Management system. This web-based system, which Broadridge added to its solution set with its acquisition of ClearStructure Financial technology, allows MUFG Investor Services to manage all aspects of
Omnes-backed Intys has acquired Univers Retail, a management and operational strategy consulting firm, specialised in distribution and retail. This is the first acquisition completed by the Belgian consultancy firm since Omnes invested in the company in July 2019.
Based in Brussels, Intys is one of the leading consulting firms in Belgium. As a multi-specialist player, Intys has a recognized expertise in the healthcare, energy, industrials and financial services sectors. Its 80 clients include leading companies and institutions in Belgium, Luxembourg and France. The firm generated a EUR35 million turnover in 2019 and has a staff of 360.
Based in
British Patient Capital has invested USD65 million in SV Health Investors’s USD265 million fund, SV7 Impact Medicine Fund (IMF), which is dedicated to investing in biotech companies.
The IMF is SV’s first biotech fund. It will aim to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.
So far the fund has invested in UK-based Alchemab, which develops antibody therapies for diseases including cancers, infectious diseases, and neurodegenerative conditions.
Cancer Research UK launched a partnership with SV Health Investors in June 2019 to focus on speeding up the translation of the organisation’s research
According to the first estimates obtained by the Spanish Venture Capital & Priivate Equity Association (ASCRI), through the European platform EDC, the volume of investment in Spain reached EUR1,434 million euros in the first half of the year, with a total number of 344 investments. Although the investment volume has suffered a drop (67 per cent less than in the same period of 2019) due to the fact that no mega-deals have been closed, the number of transactions has remained stable with respect to previous years despite the current situation. Venture Capital has been the driving force with respect to the
CAPZA has held the first closing of its CAPZA 5 Flex Equity fund at EUR450 million, exceeding the final close of its previous fund bu EUR100 million.This first closing confirms the renewed confidence of CAPZA’s historical investors (family offices, insurers, funds of funds, public institutions, pension funds) as well as strong interest from new French and international investors.
This fifth vintage – with a target size of around EUR500 million – has leveraged CAPZA’s proven approach since 2004 by providing – as lead investor – flexible financing solutions combining majority or minority capital, convertible bonds and mezzanine. The Fund aims
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
